Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-026877
Filing Date
2025-09-08
Accepted
2025-09-08 17:15:26
Documents
1
Period of Report
2025-09-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2171
  Complete submission text file 0001641172-25-026877.txt   3647
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 529 EAST CROWN POINT ROAD, SUITE 250 C/O ICORECONNECT INC. OCOEE FL 34761
Business Address
Chambers Adam V (Reporting) CIK: 0002068219 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41488 | Film No.: 251300867